Beyond the flavour: The potential druggability of chemosensory G protein-coupled receptors

Antonella Di Pizio* (First Author), Maik Behrens (Co-Author), Dietmar Krautwurst (Last Author)

*Corresponding author for this work

Research output: Contribution to journalReview article / Perspectivespeer-review

62 Scopus citations

Abstract

G protein-coupled receptors (GPCRs) belong to the largest class of drug targets. Approximately half of the members of the human GPCR superfamily are chemosensory receptors, including odorant receptors (ORs), trace amine-associated receptors (TAARs), bitter taste receptors (TAS2Rs), sweet and umami taste receptors (TAS1Rs). Interestingly, these chemosensory GPCRs (csGPCRs) are expressed in several tissues of the body where they are supposed to play a role in biological functions other than chemosensation. Despite their abundance and physiological/pathological relevance, the druggability of csGPCRs has been suggested but not fully characterized. Here, we aim to explore the potential of targeting csGPCRs to treat diseases by reviewing the current knowledge of csGPCRs expressed throughout the body and by analysing the chemical space and the drug-likeness of flavour molecules.

Original languageEnglish
Article number1402
JournalInternational Journal of Molecular Sciences
Volume20
Issue number6
DOIs
StatePublished - 2 Mar 2019

Keywords

  • Chemosensory receptors
  • Drugs
  • Ecnomotopic expression
  • Flavour molecules
  • Smell
  • Taste

Fingerprint

Dive into the research topics of 'Beyond the flavour: The potential druggability of chemosensory G protein-coupled receptors'. Together they form a unique fingerprint.

Cite this